Deputy Head of the Sanitary-Epidemiological Welfare and Public Health Service, Doctor of Medical Sciences Nurmat Otabekov answered questions from the press service of the Health Ministry about clinical trials of coronavirus vaccines launched in Uzbekistan.
We know that our compatriots are participating in the COVID-19 vaccine tests as volunteers. What are the procedures for participating in the clinical trials, and what are the requirements for volunteers? Or can anyone participate in them?
- It is known that the country is participating in phase III clinical trials of the vaccine to test its effectiveness. Volunteers aged 18 and older are involved in the tests. Initially, all volunteers undergo a medical examination, blood samples are tested in a laboratory for coronavirus disease, and those who have the infection and have antibodies to it are excluded from the testing process. The health of each person involved in this event will be monitored throughout the entire trial.
It should be noted that patients with chronic diseases and fever, high blood pressure, blood diseases, immunodeficiency, cancer, as well as pregnant women cannot participate in this process.
In the current clinical trials, more than 400 volunteers have been vaccinated. If anyone would like to participate in the testing process as a volunteer, they will soon be able to apply to a special site set up by the Ministry of Innovation Development.
The first and second clinical trials of this vaccine were conducted in China and were rated as very successful.
The Ministry of Health and the Sanitary-Epidemiological Welfare and Public Health Service are constantly monitoring the implementation of phase III clinical trials. According to the data available in the system, no post-vaccination reactions and adverse complications have been observed among vaccinated volunteers so far, and medical supervision has been established for each vaccinated individual.